COMMUNIQUÉS West-GlobeNewswire

Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

26/09/2024 - 15:05

Exploring potential partnership and strategic opportunities for the Company’s cellular therapy program in Alzheimer’s disease Highlighting the Company’s cellular therapy contract development and manufacturing business [...]

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing

26/09/2024 - 15:00

DALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This [...]

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025

26/09/2024 - 15:00

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to January 31, 2025. Accordingly, any shares of the [...]

Hapbee Appoints Mr. Abdulla Al Zain to Board of Directors

26/09/2024 - 15:00

Appointment indicates Hapbee’s commitment to expand in the Middle East and globally MONTRÉAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- CNW Telbec/ - Hapbee Technologies, Inc. (TSXV: HAPB ) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" [...]

Units for Debt Settlement

26/09/2024 - 14:46

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a transaction to settle an aggregate total [...]

OneMedNet Announces Additional $1.7 Million Private Placement

26/09/2024 - 14:45

MINNEAPOLIS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health [...]

International Myeloma Foundation to Hold First Latin American Myeloma Network Summit in Brazil on September 28

26/09/2024 - 14:45

The inaugural IMF Latin American Myeloma Network Summit will take place on Saturday, September 28, after the International Myeloma Society (IMS) Meeting in Rio De Janeiro, Brazil RIO DE JANEIRO, Brazil, Sept. 26, 2024 ( [...]

Fortress Biotech to Participate in October 2024 Investor Conferences

26/09/2024 - 14:30

MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders [...]

Interim results for the six months ended June 30, 2024

26/09/2024 - 14:30

September 26, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage [...]

Montreal hosts the 4th International Symposium on Arthrogryposis Multiplex Congenita (AMC)

26/09/2024 - 14:30

MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- From September 28 to October 1, the Shriners Hospitals for Children - Canada will host the 4 th International Symposium on Arthrogryposis . Organized in collaboration with [...]

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024

25/09/2024 - 22:30

PHILADELPHIA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed [...]

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

25/09/2024 - 22:05

CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company [...]

MDxHealth Announces Launch of Offering of Ordinary Shares

25/09/2024 - 22:05

MDxHealth Announces Launch of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM –September 25, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (“ mdxhealth ” or the “ Company ”), a commercial-stage [...]

BioVie Inc. Announces Closing of Public Offering

25/09/2024 - 22:05

CARSON CITY, Nev., Sept. 25, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]

PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples

25/09/2024 - 22:05

PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA stabilization from urine // QIAGEN to commercialize set with the [...]

Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024

25/09/2024 - 22:05

AUSTIN, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an updated analysis of data [...]

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

25/09/2024 - 22:05

Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global [...]

ImPact Biotech to Present at Oppenheimer Private Life Sciences Company Showcase

25/09/2024 - 22:01

TEL AVIV, Israel, Sept. 25, 2024 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid [...]

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

25/09/2024 - 22:01

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model Abivax [...]